The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 23.00
Ask: 27.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 25.00
High: 25.00
Low: 25.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Emma Hardie, Trading in own shares & TVR

27 Sep 2022 07:00

RNS Number : 7140A
Creightons PLC
27 September 2022
 

27 September 2022

 

CREIGHTONS plc ("Creightons" or the "Company")

Update on acquisition of Emma Hardie Limited

Trading in own shares and TVR

 

Creightons plc (LSE: CRL), manufacturers of personal care, beauty, and fragrance products, announces that further to the sale and purchase agreement ("SPA") relating to the acquisition of the entire share capital of Emma Hardie Limited as announced on 28 July 2021, the Company's subsidiary Potter and Moore Limited (P&M") has now made the final payment due to be made under the SPA to the sellers, and the Company and P&M has also entered into a settlement and share buyback agreement (the "Agreement") with the sellers in respect of certain matters related to the acquisition.

Final Payments to the Sellers under the SPA

The consideration for the transaction was approximately £6.36 million, comprising £5 million in cash and the issue of 1,600,000 ordinary shares of 1p each in the Company at the volume weighted average middle market CRL quoted price for the preceding 5 Business Days of 84.78p per share ("Consideration Shares"). Under the SPA, if on the date of twelve months from completion the volume weighted average middle market quoted price of an Ordinary Share for the last 5 Business days prior to that date (as derived from the Daily Official List of London Stock Exchange Plc) were to be less than £1.25, then an additional amount would be payable to the sellers in cash equal to such difference in price multiplied by the number of Consideration Shares issued. Having calculated the amounts due in accordance with the provisions of the SPA, the Company and each of the two sellers have now agreed the due amounts to be £666,832 per seller, being a total due amount of £1,333,664. P&M has made this payment to those sellers on 26 September 2022.

The additional payments due under the SPA comprising the adjustment payment and the deferred payment amounting in aggregate to £90,336 have also now been made to the sellers and no further amount is due to be paid by the Company or by P&M under the SPA.

Separate Share Buy Back of the Consideration Shares

Separately, it has been agreed with the two sellers that the Company buy back 800,000 Consideration Shares from each of them for a consideration of £288,000, being an aggregate consideration of£576,000 (together the "Buyback"). The consideration is based on the price of 36p per ordinary share being the on-market price at the time of the transaction. The Buyback took place on 26 September 2022.

The Company intends the total of 1,600,000 re-purchased shares to be held as treasury shares.

Accordingly, following the Buyback the Company's issued share capital now consists of 68,417,983 ordinary shares with voting rights (excluding treasury shares), with 1,600,000 ordinary shares held in treasury.

The above figure of 68,417,983 may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Mr Bernard Johnson Managing Director of the Company commented:

'We are pleased to announce the finalisation of the consideration for the acquisition of Emma Hardie Limited including the share buyback. Emma Hardie represents our first premium skincare brand and we remain confident that it will deliver significant return to shareholders in the years ahead.' 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

Enquiries - Analysts and Investors:

Nicholas O'Shea, Director, Creightons Plc 01733 281000

Roland Cornish / Felicity Geidt, Beaumont Cornish Limited 0207 628 3396

Press Nigel Szembel, Anagallis Communications Limited 07802 362088

nigelszembel@anagallis.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSAALIRFIF
Date   Source Headline
16th Feb 20107:00 amRNSInterim Management Statement
29th Jan 20101:34 pmRNSHolding(s) in Company
25th Nov 20097:00 amRNSHalf Yearly Report
30th Sep 20093:20 pmRNSDirector/PDMR Shareholding
23rd Sep 20094:41 pmRNSResult of AGM
17th Aug 20097:00 amRNSInterim Management Statement
30th Jun 200910:02 amRNSFinal Results
16th Feb 20099:22 amRNSInterim Management Statement
26th Nov 20087:00 amRNSInterim Results
26th Aug 20084:03 pmRNSResult of AGM
19th Aug 20082:13 pmRNSInterim Management Statement
26th Jun 20082:44 pmRNSFinal Results
14th Apr 200810:51 amRNSChange of Adviser Name
28th Nov 20079:27 amRNSInterim Results
21st Nov 20079:13 amRNSResult of AGM
7th Aug 200712:00 pmRNSHolding(s) in Company
27th Jul 20079:46 amRNSFinal Results
2nd May 20072:44 pmRNSDirector/PDMR Shareholding
16th Mar 20079:26 amRNSHolding(s) in Company
2nd Feb 200711:23 amRNSHolding(s) in Company
20th Dec 20063:15 pmRNSInterim Results
18th Dec 200612:03 pmRNSTotal Voting Rights
14th Dec 200610:36 amRNSResult of AGM
3rd Nov 20063:54 pmRNSHolding(s) in Company
3rd Oct 20065:56 pmRNSHolding(s) in Company
3rd Oct 20065:34 pmRNSHolding(s) in Company
26th Sep 20061:50 pmRNSHolding(s) in Company
18th Sep 20064:31 pmRNSDirector/PDMR Shareholding
4th Aug 20062:32 pmRNSHolding(s) in Company
26th Jul 200611:41 amRNSFinal Results
30th May 20063:09 pmRNSDirectorate Change
24th May 20063:39 pmRNSDirector/PDMR Shareholding
26th Apr 20066:29 pmRNSCorrection - Director Holding
3rd Apr 200610:29 amRNSDirector/PDMR Shareholding
31st Mar 20066:09 pmRNSDirector/PDMR Shareholding
22nd Dec 20055:45 pmRNSInterim Results
20th Dec 200512:06 pmRNSResult of AGM
27th Jul 20055:17 pmRNSFinal Results
14th Jul 20054:02 pmRNSDirectorate Change
5th Jul 20054:47 pmRNSChange of Address
30th Jun 20053:30 pmRNSResult of EGM
13th Jun 20054:40 pmRNSNotice of EGM
18th May 200510:37 amRNSDisposal
4th Apr 200510:25 amRNSDisposal
13th Jan 20057:00 amRNSAppointment of adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.